BioSpace News Archive

Sollis Therapeutics, Inc., an Ohio-based interventional pain therapeutics company, announced that the first patient was enrolled in the RePRIEVE-CM trial, a Phase 3 clinical trial evaluating the efficacy and safety of the extended release non-opioid, non-steroid clonidine micropellet for the treatment of sciatica pain.

Canada`s agricultural sector is working hard to boost productivity, efficiency and income, while meeting the challenge of feeding the world sustainably

Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka), a global leader in the development of digital and traditional treatments for mental illness, together with honorary co-host U.S. Representative Bonnie Watson Coleman (NJ-12) hosted a roundtable discussion of the expanding role of technology in the future of healthcare and its potential to break down barriers to care and support patient outcomes.

Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm”), today announced the closing of its initial public offering of 4,600,000 shares of common stock, at a price to the public of $14.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to an additional 600,000 shares of common stock

CENTOGENE today announced the launch of CentoPharma 1.0, the world’s first CE labeled platform for targeted patient cohort identification.

The U.S. Food and Drug Administration is committed to animal welfare in research by reducing, replacing and/or refining the use of animals in research, whenever possible.

The Ontario Bioscience Innovation Organization (OBIO®), the leading advocate for Ontario’s health science industry, is pleased to announce a call for applications for the 2019 OBIO Capital Access Advisory Program (CAAP®).

USP announced today that Susan C. Winckler, R.Ph., J.D., has been elected chair of its board of trustees.

J & B Medical Supply has announced majority ownership of the Sylaps Inc. platform.

The American Pharmacists Association (APhA) has signed on as a supporting organization for the recently released 2018 AHA/ACC Guideline on the Management of Blood Cholesterol.